A hysterectomy removes the uterus and, in most cases, the cervix, but it does not reliably eliminate human papillomavirus from the body. HPV is a virus that lives in surface tissue cells, and it can persist in vaginal tissue, vulvar skin, and other areas the surgery never touches. In one study tracking patients after surgery for early-stage cervical cancer, about 88% cleared their HPV infections within a year, but a meaningful minority carried the virus well beyond that point. The question of whether HPV “goes away” after a hysterectomy turns out to depend on several factors the surgery itself cannot control.
Why Removing the Uterus Does Not Remove the Virus
HPV infects the thin surface cells of the skin and mucous membranes. The cervix is the most common site of high-risk infection, but the virus also lives in vaginal wall tissue, vulvar skin, and the area around the anus. When a surgeon removes the uterus and cervix, any HPV already living in the remaining vaginal cuff or surrounding tissue stays behind. One case report documented a woman whose vaginal tissue showed obviously increased HPV DNA levels after a complete hysterectomy, and she was diagnosed with vaginal cancer just six months later.1PubMed Central. Post-hysterectomy vaginal cuff cancer secondary to HPV infection and CIN: A case report That case is extreme, but it illustrates the core problem: the surgery targets the organ, not the virus.
A 2024 review of post-hysterectomy vaginal lesions concluded that the real risk factors are a history of HPV-related disease in the lower genital tract and viral persistence, rather than the hysterectomy itself.2PubMed Central. Vaginal Intraepithelial Neoplasia (VaIN) after Hysterectomy Is Strongly Associated with Persistent HR-HPV Infection In other words, the women most likely to have HPV linger after surgery are the same women who had the most persistent infections before surgery. The operation changes the anatomy but does not reset the immune battle already underway.
How Often HPV Actually Clears After Surgery
Most people do clear HPV after a hysterectomy, and the clearance rates are encouraging. A 2025 study following patients after surgery for early-stage cervical cancer found that roughly 88% tested HPV-negative within 12 months. Among the remaining patients, some cleared by 24 months, but eight individuals were still testing positive beyond two years.3Frontiers in Oncology. Investigating the impact of persistent HPV infection on recurrence of lesions post-surgery for early-stage cervical cancer and related influencing factors Three of those persistent cases carried the same genotypes detected before surgery, confirming that the original infection had simply not been eliminated.
A separate study comparing HPV clearance after hysterectomy versus a less radical procedure (conization, where only a cone-shaped section of the cervix is removed) found that the clearance rates were nearly identical. At 12 months, about 80% of hysterectomy patients had cleared HPV types 16 and 18, compared with about 79% of conization patients.4PubMed Central. Postoperative clearance of high-risk human papillomavirus for patients with high-grade squamous intraepithelial lesion: Conization versus hysterectomy That finding is worth sitting with. A much bigger surgery did not produce meaningfully better viral clearance. The immune system is doing the heavy lifting in both cases, not the scalpel.
Total Versus Subtotal Hysterectomy
The type of hysterectomy matters in a way many patients do not expect. A total hysterectomy removes the entire uterus including the cervix. A subtotal (also called supracervical) hysterectomy removes the uterus but leaves the cervix in place. If you had a subtotal hysterectomy, your cervix is still there, and it can still harbor HPV and develop cervical disease. Case reports have documented lesions arising in the retained cervical stump years later.5PubMed Central. Large pelvic mass arising from the cervical stump: A case report
If you are unsure which type you had, your surgical records will specify. Women who had a subtotal hysterectomy still need routine cervical screening, because they still have a cervix. This is a surprisingly common point of confusion, and it has real consequences for follow-up care.
What Increases the Risk of HPV Sticking Around
Several factors make it harder for your body to clear HPV after surgery, and they interact with each other in ways that compound the risk.
- Surgical margins: If the edges of the removed tissue showed cancer cells or abnormal tissue (called positive margins), the odds of HPV persisting are considerably higher. One study identified positive vaginal incision margins as an independent risk factor, roughly tripling the odds of persistent infection after cervical cancer surgery.6Diagnostic Microbiology and Infectious Disease. Factors associated with the persistence of human papillomavirus after surgery in patients with cervical cancer A separate review confirmed that positive margins indicate residual disease and represent a major risk factor for recurrence.7Frontiers in Oncology. Research progress on HPV-related vaginal wall lesions after hysterectomy
- Menopause: Postmenopausal patients had roughly a 45% increased risk of still testing HPV-positive at follow-up visits compared to premenopausal patients, with the difference most pronounced in the first two years after treatment.8BioMed Central / Springer Nature (BMC Infectious Diseases). Cervical conization and high risk – HPV status changes in relation to menopause: a retrospective longitudinal study based on generalized additive mixed models The same factor showed up as an independent predictor of persistence in the surgical-margin study.6Diagnostic Microbiology and Infectious Disease. Factors associated with the persistence of human papillomavirus after surgery in patients with cervical cancer Lower estrogen levels after menopause thin the vaginal lining and alter local immune responses, giving the virus less resistance to fight against.
- Smoking and immunosuppression: In a study of women who had hysterectomies for persistent cervical dysplasia, more than a third were smokers and about 15% were immunosuppressed.9Journal of Lower Genital Tract Disease. Outcomes of Women Who Underwent Hysterectomy for Persistent Cervical Dysplasia Both factors weaken the immune system’s ability to suppress the virus.
- HPV genotype: High-risk types, especially HPV 16 and 18, were significantly more common in women who developed vaginal intraepithelial neoplasia (VaIN) after hysterectomy.10Cancer Letters. Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection These genotypes are harder for the immune system to clear and are responsible for the vast majority of HPV-related cancers.
Latent Infections and the Reactivation Problem
One of the most unsettling aspects of HPV biology is that the virus can go dormant in tissue at levels too low for standard tests to detect, then reactivate years or even decades later. A Danish study specifically investigated this in older women who had a history of cervical dysplasia. Among women with no detectable active infection at the time of surgery, researchers used a more sensitive technique to look for dormant virus. They found latent HPV in about 58% of the women tested, with HPV 16 accounting for half of those latent infections.11PubMed Central. Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia
This has practical implications for post-hysterectomy patients. A negative HPV test after surgery does not necessarily mean the virus is gone from your body. It may mean the virus is suppressed below the detection threshold, held in check by your immune system. If immune function later declines due to aging, medication (such as immunosuppressive drugs for an organ transplant or autoimmune disease), or other health changes, the virus can reactivate and cause new lesions in the remaining vaginal tissue. This is the biological reason why follow-up screening remains important for certain patients long after surgery.
HPV in the Vaginal Tissue of Hysterectomized Women
A population-based study comparing HPV detection in women who had undergone hysterectomy versus those who had not found something unexpected. Non-cancer-associated HPV types (like types 61, 71, and 72) were actually detected more frequently in vaginal specimens from hysterectomized women (about 24%) than in cervical specimens from non-hysterectomized women (about 17%).12The Journal of Infectious Diseases. A Population-Based Study of Vaginal Human Papillomavirus Infection in Hysterectomized Women However, there was no difference in the prevalence of cancer-associated types between the two groups. In both groups, having more lifetime sexual partners was associated with higher HPV prevalence.
This study is a good reminder that HPV is extremely common, and that new vaginal HPV infections can occur after hysterectomy through sexual contact, entirely independent of whatever infection prompted the surgery. The virus does not need a cervix to establish itself. Vaginal tissue is a perfectly hospitable host.
Do You Still Need Screening After a Hysterectomy?
This is where the answer splits sharply depending on why the hysterectomy was performed. The U.S. Preventive Services Task Force concluded with high certainty that screening women who had a hysterectomy for reasons unrelated to cervical cancer or high-grade precancerous changes produces more harm than benefit.13JAMA. Screening for Cervical Cancer If your uterus was removed because of fibroids, heavy bleeding, endometriosis, or other benign conditions, and you had no history of significant cervical abnormalities, continued cervical or vaginal screening is generally not recommended.
The picture changes entirely if you had a hysterectomy because of cervical cancer, high-grade dysplasia, or persistent HPV-related disease. In that case, ongoing vaginal cuff screening with HPV testing is typically recommended for at least 20 to 25 years after treatment, because these patients face a real risk of vaginal lesions. A multi-center study specifically examined the development of lower genital tract dysplasia (including vaginal, vulvar, and anal lesions) in women who had hysterectomies for high-grade cervical disease or early-stage cervical cancer.14PubMed. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination The fact that such a study exists underscores that this is a recognized clinical problem, not a rare edge case.
If you have had a hysterectomy and are unsure whether you still need HPV-related screening, the answer depends on whether your cervix was removed (total versus subtotal), the reason for surgery, and whether there was any history of abnormal cervical cells. Your gynecologist should have this information, and it is worth asking directly.
The Vaginal Microbiome and HPV Clearance
Emerging research suggests that the bacterial environment in the vagina plays a role in whether HPV clears or persists after treatment. In a prospective study of women treated surgically for high-grade cervical lesions, about 79% cleared their high-risk HPV by the six-month follow-up, and none of the women who cleared the virus had a clinical recurrence. Among the roughly 21% who still had persistent HPV, about 28% went on to develop recurrent disease.15Frontiers in Cellular and Infection Microbiology. Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study
What stood out in that study was the microbiome data. Women who cleared HPV showed a dramatic increase in Lactobacillus crispatus, a beneficial bacterium associated with a healthy vaginal environment, and a corresponding drop in species linked to bacterial vaginosis. Women whose HPV persisted showed almost no change in their microbiome composition. Pro-inflammatory markers also dropped significantly in the clearance group but stayed elevated in the persistence group. The researchers could not determine whether a healthier microbiome helped clear the virus or whether successful viral clearance allowed the microbiome to recover, but the association was strong either way.
This area of research is still relatively young, and nobody should interpret it as “take a probiotic to cure HPV.” But it does suggest that vaginal health and immune environment matter for viral clearance in ways that go beyond traditional risk factors like smoking or age. It is also a reminder that the body’s response to HPV is not purely a matter of antibodies and T-cells fighting the virus in isolation. The local tissue environment matters.
HPV Vaccination After Hysterectomy
A question that comes up increasingly in clinical settings is whether HPV vaccination after treatment for cervical disease can reduce the risk of future HPV-related problems. There is reasonable biological logic behind the idea. Vaccination generates antibodies against the most dangerous HPV types, and data from studies of vaccination after treatment for precancerous lesions show some benefit. However, the European Society of Gynecological Oncology reviewed the evidence and found that no data currently supports using the HPV vaccine specifically to prevent recurrence in patients already diagnosed with HPV-related cancers.16PubMed Central. Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion
Their recommendation is pragmatic rather than discouraging: counsel these patients the same way you would counsel anyone else about vaccination, based on age and general health. If you are eligible for the HPV vaccine by age and have not been vaccinated, it still makes sense to get it regardless of your surgical history, because it can protect against HPV types you have not yet encountered. But do not expect it to function as a treatment for an existing infection or a guarantee against recurrence of a type you already carry.
The Psychological Weight of a Virus That Lingers
What often gets lost in clinical discussions is the emotional toll of learning that HPV can persist after a hysterectomy. Many women who undergo the surgery for cervical cancer or severe dysplasia expect it to be definitive. Learning that follow-up tests are still positive, or that continued screening is necessary, can feel like the problem was never really solved. Case reports have documented significant psychological distress in patients dealing with persistent HPV-related disease after hysterectomy, including anxiety and fear that the condition is incurable.17Asian Journal of Oncology. Homeopathic resolution of HPV-related genital warts following robotic hysterectomy: A case report
That distress is understandable and worth naming. HPV carries social stigma on top of its medical implications, and the combination of a major surgery followed by continued positive tests can feel demoralizing. If you are in this situation, it helps to know that most persistent infections do eventually clear, that having detectable HPV does not mean cancer is imminent, and that the purpose of follow-up screening is to catch any rare problems early, when they are most treatable. Continued HPV positivity after a hysterectomy is a reason for monitoring, not panic.
When New Partners Enter the Picture
Some women assume that after a hysterectomy, HPV is no longer relevant to their sexual health. The population data say otherwise. The study of hysterectomized women found that having more lifetime sexual partners was associated with higher HPV detection, the same pattern seen in women who still had a cervix.12The Journal of Infectious Diseases. A Population-Based Study of Vaginal Human Papillomavirus Infection in Hysterectomized Women New sexual partners can introduce new HPV types, and the vaginal tissue remains susceptible to infection regardless of whether the uterus is present. Barrier methods like condoms reduce HPV transmission but do not eliminate it, since the virus can infect skin and mucous membranes that condoms do not cover.
This is relevant not only for your own health but for a partner’s. If you carry a high-risk HPV type, transmission remains possible through sexual contact. There is no practical way to test men for HPV in routine clinical settings, so the virus circulates largely invisibly through the population. Being aware that HPV does not end with a hysterectomy helps you make informed decisions about your sexual health and your screening schedule going forward.